OCM
One Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $822K | Sell |
12,830
-11,033
| -46% | -$707K | 0.03% | 276 |
|
|
2025
Q1 | $1.51M | Sell |
23,863
-276
| -1% | -$17.5K | 0.05% | 189 |
|
|
2024
Q4 | $1.61M | Sell |
24,139
-214
| -0.9% | -$14.2K | 0.05% | 173 |
|
|
2024
Q3 | $1.7M | Sell |
24,353
-1,049
| -4% | -$73.2K | 0.05% | 179 |
|
|
2024
Q2 | $1.65M | Buy |
25,402
+6,137
| +32% | +$398K | 0.06% | 178 |
|
|
2024
Q1 | $1.25M | Sell |
19,265
-534
| -3% | -$34.6K | 0.05% | 169 |
|
|
2023
Q4 | $1.3M | Buy |
+19,799
| New | +$1.3M | 0.05% | 168 |
|